T1	disease_or_phenotypic_feature 24 39	Type 2 diabetes
T2	disease_or_phenotypic_feature 44 53	cataracts
T3	chemical 88 94	oxygen
T4	chemical 169 175	oxygen
T5	disease_or_phenotypic_feature 190 198	cataract
T6	chemical 267 273	oxygen
T7	disease_or_phenotypic_feature 305 318	heart failure
T8	chemical 349 361	nitric oxide
T9	chemical 371 381	inhibitors
T10	disease_or_phenotypic_feature 437 443	cancer
T11	disease_or_phenotypic_feature 491 498	obesity
T12	chemical 502 508	oxygen
T13	chemical 557 566	Sirolimus
T14	chemical 591 595	drug
T15	disease_or_phenotypic_feature 636 642	anemia
T16	disease_or_phenotypic_feature 704 715	early tumor
T17	chemical 794 804	biological
T18	chemical 882 892	biomarkers
T19	disease_or_phenotypic_feature 896 911	prostate cancer
T20	disease_or_phenotypic_feature 913 939	Sensorineural hearing loss
T21	chemical 943 950	antigen
T22	disease_or_phenotypic_feature 959 971	otitis media
T23	chemical 974 985	Biochemical
T24	disease_or_phenotypic_feature 995 1003	cataract
T25	disease_or_phenotypic_feature 1044 1050	cancer
T26	chemical 1066 1072	folate
T27	chemical 1105 1112	heparin
T28	chemical 1141 1145	drug
T29	disease_or_phenotypic_feature 1288 1309	peripheral neuropathy
T30	chemical 1328 1332	lead
T31	chemical 1392 1403	Sibutramine
T32	chemical 1452 1461	inhibitor
T33	disease_or_phenotypic_feature 1488 1495	obesity
T34	chemical 1561 1575	growth hormone
T35	disease_or_phenotypic_feature 1592 1600	adenomas
T36	chemical 1602 1612	Ethambutol
T37	chemical 1652 1656	drug
T38	disease_or_phenotypic_feature 1684 1701	visual impairment
T39	chemical 1730 1737	protein
T40	disease_or_phenotypic_feature 1776 1779	HCC
T41	disease_or_phenotypic_feature 1827 1830	HCC
T42	disease_or_phenotypic_feature 1868 1883	colon carcinoma
T43	chemical 1932 1940	antigens
T44	chemical 2033 2042	inhibitor
T45	disease_or_phenotypic_feature 2051 2069	hearing impairment
T46	disease_or_phenotypic_feature 2071 2083	Eosinophilic
T47	disease_or_phenotypic_feature 2118 2124	asthma
T48	chemical 2135 2145	pranlukast
T49	chemical 2147 2156	Cisplatin
T50	chemical 2175 2179	drug
T51	disease_or_phenotypic_feature 2241 2252	lung tumors
T52	chemical 2315 2323	androgen
T53	disease_or_phenotypic_feature 2348 2351	PAP
T54	chemical 2374 2382	androgen
T55	disease_or_phenotypic_feature 2429 2436	One-Pot
T56	chemical 2462 2471	Polyester
T57	missed_chemical 330 344	cyclooxygenase
T58	corrected_chemical 349 381	nitric oxide synthase inhibitors
R1	causes_or_contributes_to Arg1:T13 Arg2:T15	
T59	missed_disease_or_phenotypic_feature 644 667	Circulating tumor cells
T60	missed_disease_or_phenotypic_feature 1163 1168	tumor
T62	missed_disease_or_phenotypic_feature 1311 1315	CIPN
R3	treats Arg1:T31 Arg2:T33	
T64	missed_disease_or_phenotypic_feature 1529 1542	prolactinomas
R4	causes_or_contributes_to Arg1:T36 Arg2:T38	
T65	corrected_chemical 1715 1737	PcG associated protein
T66	missed_chemical 1738 1742	RYBP
T67	corrected_chemical 1915 1940	tumor-associated antigens
T68	missed_chemical 1942 1946	TAAs
T69	corrected_chemical 2008 2042	Phosphodiesterase type 5 inhibitor
R5	treats Arg1:T49 Arg2:T51	
T70	DONE 2560 2564	DONE
R6	treats Arg1:T6 Arg2:T7	
T71	corrected_disease_or_phenotypic_feature 2108 2124	bronchial asthma
R7	treats Arg1:T48 Arg2:T71	
T72	corrected_disease_or_phenotypic_feature 2071 2089	Eosinophilic tumor
R8	causes_or_contributes_to Arg1:T48 Arg2:T72	
R9	treats Arg1:T26 Arg2:T60	
T73	corrected_chemical 1409 1461	centrally acting neurotransmitter reuptake inhibitor
R10	treats Arg1:T73 Arg2:T33	
T74	corrected_chemical 1636 1656	antituberculous drug
R11	causes_or_contributes_to Arg1:T74 Arg2:T38	
T75	missed_disease_or_phenotypic_feature 2205 2211	tumors
R12	treats Arg1:T49 Arg2:T75	
T76	missed_chemical 464 475	prostanoids
T77	missed_disease_or_phenotypic_feature 437 452	cancer cachexia
R13	causes_or_contributes_to Arg1:T76 Arg2:T77	
T78	corrected_chemical 573 595	immunosuppressive drug
R14	causes_or_contributes_to Arg1:T78 Arg2:T15	
R15	causes_or_contributes_to Arg1:T21 Arg2:T22	
R16	treats Arg1:T28 Arg2:T60	
R17	treats Arg1:T26 Arg2:T25	
T79	corrected_chemical 1105 1125	heparin nanocarriers
R18	treats Arg1:T79 Arg2:T25	
R2	treats Arg1:T79 Arg2:T60	
R19	treats Arg1:T28 Arg2:T25	
T80	corrected_chemical 1267 1279	chemotherapy
R20	causes_or_contributes_to Arg1:T80 Arg2:T29	
T81	missed_disease_or_phenotypic_feature 1252 1263	side effect
R21	causes_or_contributes_to Arg1:T80 Arg2:T81	
R22	causes_or_contributes_to Arg1:T80 Arg2:T62	
T82	corrected_chemical 2163 2179	anti-cancer drug
R26	treats Arg1:T82 Arg2:T75	
R27	treats Arg1:T82 Arg2:T51	
T83	missed_disease_or_phenotypic_feature 2334 2357	Dunning R3327 PAP tumor
R28	causes_or_contributes_to Arg1:T52 Arg2:T83	
R23	causes_or_contributes_to Arg1:T69 Arg2:T45	
